HEMO-GE.ApS: Financial statements 2019
CVR: 39076322
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,780 and a net result of DKK -4,580 compared with DKK 193,715 the year before. Equity in the 2019 report amounted to DKK 2,069,988. The solvency ratio was 99.8%.
- Gross Profit
- DKK -3,780
- Profit/Loss
- DKK -4,580
- Equity
- DKK 2,069,988
- Total Assets
- DKK 2,073,738
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -4 t. | -5 t. | 2.1 mio. | - |
| 2018 | - | -7 t. | 194 t. | 2.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.